St Teresa Medical was founded in 2010 to commercialize an innovative technology developed by Virginia Commonwealth University (VCU) in collaboration with the Henry Jackson Foundation for the Advancement of Military Medicine. The technology was originally developed for treating battlefield trauma. St Teresa Medical licensed the invention from VCU and added substantial additional intellectual property to the portfolio. The company was originally named after Mother Teresa. Just as Mother Teresa was a healer and saved lives, this platform technology is designed to stop life-threatening bleeding or fluid leaks during surgery and aid in wound healing. St Teresa Medical is aimed to revolutionize the hemostatic and therapeutic markets with soft matter nanotechnology fibers to better patient outcomes and improve lives.
Founding
Secured world-wide license to technology from VCU.
Founding
Intellectual Property
Executed long-range IP strategy resulting in 43 patent applications in key U.S. & international markets.
Pre-Clinical
Completed 13+ in-vivo trials involving 5 species.
Pre-Clinical
Clinical
Completed 2 human clinical trails in the U.K., Norway, and India on Cancellous Bone Bleeding with excellent results.
Manufacturing
Successful pilot production development moving into GMP manufacturing to support commercialization.
Manufacturing
Distribution
Contracting with experienced distributors for upcoming Beta Launch
Quality
Received ISO 13485 Certification & GMP Compliance Certificate.
Quality
Regulatory
FDA Phase III IND Pending.
2915 Waters Road, Suite 108
Eagan, Minnesota 55121
Phone : 651-789-6550
Email : support@stteresamedical.com